Study Compares Drugs for Diabetes-Linked Eye Disease
A vision-robbing condition called diabetic macular edema can strike people with diabetes. Now, a new study compared three leading drugs for the condition -- Avastin, Eylea and Lucentis -- and found that Eylea came out on top, at least for patients with "moderate" vision loss. Ronald Gentile, MD, is professor of ophthalmology at the New York Ear and Eye Infirmary of Mount Sinai, in New York City, and was an investigator on the trial. He said that "the importance of this study can't be overstated. These one-year results highlight the fact that all the drugs studied -- Eylea, Avastin and Lucentis -- are potentially effective [treatment] options."
- Dr. Ronald Gentile, Professor, Ophthalmology, Icahn School of Medicine at Mount Sinai